Santiago Esteva Gras is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of rare diseases. With a total of 3 patents to his name, his work focuses on innovative solutions that address critical health issues.

Latest Patents

One of his latest patents involves the use of triamterene or nolatrexed for the treatment of phenylketonuria. This invention relates to a compound selected from a group that includes nolatrexed, triamterene, sultopride, and hydrastinine, or a pharmaceutically acceptable salt thereof. The patent outlines the use of these compounds in combination with other active ingredients for the treatment and prevention of phenylketonuria. Another significant patent is for sustained release compositions comprising micronized tolcapone. This invention details a sustained release tablet that includes micronized tolcapone, a release retardant, and a binder, aimed at preventing and treating transthyretin-associated amyloidosis.

Career Highlights

Santiago has worked with Som Innovation Biotech, S.L. and Som Innovation Biotech, S.A., where he has contributed to various innovative projects in the pharmaceutical sector. His expertise in drug formulation and development has been instrumental in advancing treatment options for patients.

Collaborations

Throughout his career, Santiago has collaborated with talented professionals, including Núria Reig Bolaño and Raúl Insa Boronat. These collaborations have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.

Conclusion

Santiago Esteva Gras is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to medical science. His work continues to impact the treatment of rare diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.